New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy-Reference-Cited by-同舟云学术

New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy

Published:2013 Issue:4 Volume:5 Page:106
ISSN:1948-0210
Container-title:World Journal of Stem Cells
language:en
Short-container-title:WJSC

Author:

Chapel Alain

Publisher

Baishideng Publishing Group Inc.

Subject

Cell Biology,Genetics(clinical),Genetics,Molecular Biology,Histology

Reference33 articles.

1. Defining pelvic-radiation disease for the survivorship era

2. NEW EMERGING CONCEPTS IN THE MEDICAL MANAGEMENT OF LOCAL RADIATION INJURY

3. Normal Tissue Complications From Low-dose Proton Therapy

4. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding

5. Endoscopic and Medical Therapy for Chronic Radiation Proctopathy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different Biocompatibility and Radioprotective Activity of Squid Melanin Nanoparticles on Human Stromal Cells;ACS Omega;2024-08-22

2. Therapeutic mechanism of Liangxue-Guyuan-Yishen decoction on intestinal stem cells and tight junction proteins in gastrointestinal acute radiation syndrome rats;Journal of Radiation Research;2023-09-11

3. Differential Cytotoxicity of Curcumin-Loaded Micelles on Human Tumor and Stromal Cells;International Journal of Molecular Sciences;2022-10-15

4. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma;International Journal of Molecular Sciences;2022-07-12

5. Human mesenchymal stromal cells maintain their stem cell traits after high-LET particle irradiation – Potential implications for particle radiotherapy and manned space missions;Cancer Letters;2022-01